Status | Study |
Completed |
Study Name: Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-03-10 Interventions: Drug: Coenzyme A Coenzyme A 40 |
Completed |
Study Name: Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter Condition: Hypercholesterolemia, Familial LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPE Date: 2012-12-13 Interventions: Device: DALI-adsorber Recordin |
Recruiting |
Study Name: Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia Condition: Type 1 Hyperlipoproteinemia Date: 2012-08-27 Interventions: Drug: SLx-4090 placebo Drug: Orlistat Plac |
Completed |
Study Name: The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2012-07-17 Interventions: Drug: Coenzyme A Coenzyme A 20 |
Active, not recruiting |
Study Name: Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) Condition: Hyperlipoproteinemia Type II Heterozygous Familial Hypercholest Date: 2012-01-30 Interventions: Drug: Anacetrapib one 100 mg t |
Terminated |
Study Name: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Condition: Hyperlipoproteinemia Type I Date: 2011-09-28 |
Terminated |
Study Name: Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia Condition: Hyperlipoproteinemia Metabolic Syndrome Date: 2010-11-12 Interventions: Drug: Niacin/ Laropiprant 1000/ 20 mg first 4 weeks, 2000/40 mg next 8 weeks; daily |
Completed |
Study Name: Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia Condition: Hyperlipoproteinemia Date: 2010-06-09 Interventions: Drug: LCQ908 Drug: Placebo |
Withdrawn |
Study Name: Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) Condition: Hyperlipoproteinemia(a) Progressive Cardiovascular Disease Date: 2010-02-08 Interventions: Procedure: Lipid apheresis Wee |
Completed |
Study Name: A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin Condition: Hypercholesterolemia Hyperlipoproteinemia Date: 2010-01-26 Interventions: Drug: Pravastatin Pravastatin |